Further evidence for amyloid deposition in clinical pancreatic islet grafts

Transplantation

Volumn 93, Issue 2, 2012, Pages 219-223

  Westermark, Gunilla T ^a   Davalli, Alberto M ^b   Secchi, Antonio ^b   Folli, Franco ^c   Kin, Tatsuya ^d   Toso, Christian ^d,e   Shapiro, A M James ^d   Korsgren, Olle ^a   Tufveson, Gunnar ^a   Andersson, Arne ^a   Westermark, Per ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Beta cell; Islet amyloid; Islet graft; Transplant pathology; Type 1 diabetes

Indexed keywords

AMYLIN; AMYLOID; AZATHIOPRINE; C PEPTIDE; CYCLOSPORIN A; DACLIZUMAB; HEMOGLOBIN A1C; INSULIN; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADULT; AMYLOIDOSIS; ANTIBODY LABELING; ARTICLE; CASE REPORT; CELL LOSS; FEMALE; GRAFT REJECTION; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER PARENCHYMA; MALE; PANCREAS ISLET BETA CELL; PANCREAS ISLET DISEASE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL;

ADULT; DIABETES MELLITUS, TYPE 1; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER; MALE; MIDDLE AGED; PROPROTEIN CONVERTASE 2; TISSUE DONORS;

EID: 84855858944     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31823e46ef     Document Type: Article

References (21)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
3. Westermark GT, Westermark P, Berne C, et al. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med 2008; 359: 977.
4. Westermark P, Eizirik DL, Pipeleers DG, et al. Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 1995; 38: 543.
5. Westermark GT, Westermark P, Nordin A, et al. Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Ups J Med Sci 2003; 108: 193.
6. Hull RL, Westermark GT, Westermark P, et al. Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 3629.
7. Khemtemourian L, Killian JA, Hoppener JW, et al. Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus. Exp Diabetes Res 2008; 2008; 421287.
8. Davalli AM, Perego L, Bertuzzi F, et al. Disproportionate hyperproinsulinemia, beta-cell restricted prohormone convertase 2 deficiency, and cell cycle inhibitors expression by human islets transplanted into athymic nude mice: Insights into nonimmune-mediated mechanisms of delayed islet graft failure. Cell Transplant 2008; 17: 1323.
9. Toso C, Isse K, Demetris AJ, et al. Histologic graft assessment after clinical islet transplantation. Transplantation 2009; 88: 1286.
10. Davalli AM, Maffi P, Socci C, et al. Insights from a successful case of intrahepatic islet transplantation into a type 1 diabetic patient. J Clin Endocrinol Metab 2000; 85: 3847.
11. Westermark G, Westermark P, Eizirik DL, et al. Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice. Metabolism 1999; 48: 448.
12. Finzi G, Davalli A, Placidi C, et al. Morphological and ultrastructural features of human islet grafts performed in diabetic nude mice. Ultrastruct Pathol 2005; 29: 525.
13. Guardado-Mendoza R, Davalli AM, Chavez AO, et al. Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci USA 2009; 106: 13992.
14. Carlsson PO. Influence of microenvironment on engraftment of transplanted beta-cells. Ups J Med Sci 2011; 116: 1.
15. Christoffersson G, Carlsson PO, Phillipson M. Intramuscular islet transplantation promotes restored islet vascularity. Islets 2011; 3: 69.
16. Westermark P. Amyloid in the islets of Langerhans: Thoughts and some historical aspects. Ups J Med Sci 2011; 116: 81.
17. Potter KJ, Abedini A, Marek P, et al. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci USA 2010; 107: 4305.
18. Paulsson JF, Andersson A, Westermark P, et al. Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets. Diabetologia 2006; 49: 1237.
19. Janson J, Soeller WC, Roche PC, et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 1996; 93: 7283.
20. Westermark GT, Johnson KH, Westermark P. Staining methods for identification of amyloid in tissue. Methods Enzymol 1999; 309: 3.
21. Paulsson JF, Westermark GT. Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation. Diabetes 2005; 54: 2117.